Beam Therapeutics Inc.

Beam Therapeutics pioneers precision base‑editing biotech, advancing a pipeline of rare‑disease treatments (BEAM‑101, 302, 301, 201) supported by partnerships with Pfizer, Apellis, Verve, and Sana.

Headquarters: United States (USA)

Beam Therapeutics Inc. Logo
Company Profile
  • Employees: 510
  • HQ: Cambridge
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
BEAM Beam Therapeutics Inc.
Cap: 2.8B
EQUITY NMS USD US07373V1052 Active
📈
Home Login